INSIGHTS ON DRUG DEVELOPMENT

  • MAPK Signaling Pathway

    Mitogen-activated protein kinase cascades regulate key cellular processes like proliferation, differentiation, and apoptosis. Explore how these pathways maintain cellular homeostasis and contribute to disease development.

  • Ophthalmic Drug Delivery

    Explore the challenges to effective delivery of drugs to the eye, intricacies of ophthalmic drug delivery, and advantages of nanoparticles as an enabling technology for ocular drug-delivery systems.

  • Optimize Your RNA-LNP Delivery With Ionizable Lipids

    Ionizable lipids play a crucial role in optimizing LNP delivery. Discover how lipid nanoparticles revolutionize intracellular drug delivery to enhance RNA vaccines, cell therapies, protein replacement, and gene editing.

  • How Recent Trends Impact Bringing Your Molecule To Market

    With accelerated approval times, growing competition between drugs, and a shift from hospital to home care, you’re under pressure to develop a delivery device in parallel with your drug.

  • Thunderstruck By Antibody-Drug Conjugates
    3/18/2025

    Antibody-drug conjugates are transforming cancer treatment by targeting tumors directly to reduce side effects. Discover how they affect neighboring cells, which can enhance treatment efficacy and eliminate tumor cell populations.

  • Automated Bioburden Testing Solution
    11/7/2025

    Automation is transforming microbial quality control labs, boosting productivity, minimizing errors, and ensuring data integrity. Discover how digitalization is driving Pharma 4.0 and reshaping lab workflows.

  • 2D To 3D Transition Of Mesenchymal Stem Cell Expansion Process
    4/4/2025

    Discover how transitioning from 2D to 3D culture methods enhances the scalability, yield, and quality of Mesenchymal Stem Cells (MSCs) for therapeutic applications to address critical manufacturing challenges.

  • Real-Time Growth Monitoring Of Spheroids In Round Bottom Microplates
    11/7/2025

    Real-time spheroid monitoring combines brightfield and fluorescence imaging with automated analysis. Find out how this workflow enhances reproducibility and supports high-content 3D cell culture applications.

  • 5 Trends Impacting CMOs In 2025
    2/4/2025

    In 2025, CMOs will navigate Annex 1 compliance, the BioSecure Act’s uncertainty, AI-driven drug development, supply chain challenges from tariffs, and pandemic preparedness strategies.

DRUG DEVELOPMENT SOLUTIONS

  • Societal specializes in modified-release formulations, including those for high potent and DEA controlled substances.

  • The THUNDER Imager Tissue allows real-time fluorescence imaging of 3D tissue sections typically used in neuroscience and histology research. Acquire rich, detailed images of thick tissues free of haze from out-of-focus blur.

    Even fine structures deep in tissues can be resolved thanks to Computational Clearing, an innovative Leica technology. Image detailed morphological structures like axons and dendrites of neurons in a brain slice. The high image quality, even with thick tissue sections, is combined with the well-known speed, fluorescence efficiency, and ease of use of widefield microscopes.

  • Use a real-time PCR (qPCR) solution for testing cell therapy products that provides sterility results in less than 5 hours.

    • Enables sample recovery
    • Avoids dilution effects
    • Analyzes samples in a matrix-free environment
    • Has minimal buffer constraints
  • MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.